Article

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

Department of Medicine and Therapeutics, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong.
Gut (Impact Factor: 13.32). 10/2004; 53(9):1244-9. DOI: 10.1136/gut.2003.034629
Source: PubMed

ABSTRACT Gastric intestinal metaplasia (IM) is generally considered to be a precancerous lesion in the gastric carcinogenesis cascade. This study identified the risk factors associated with progression of IM in a randomised control study.
A total of 587 Helicobacter pylori infected subjects were randomised to receive a one week course of anti-Helicobacter therapy (omeprazole, amoxicillin, and clarithromycin (OAC)) or placebo. Subjects underwent endoscopy with biopsy at baseline and at five years. Severity of IM was graded according to the updated Sydney classification and progression was defined as worsening of IM scores at five years in either the antrum or corpus, or development of neoplasia. Backward stepwise multiple logistic regression was used to identify independent risk factors associated with IM progression.
Of 435 subjects (220 in the OAC and 215 in the placebo group) available for analysis, 10 developed gastric cancer and three had dysplasia. Overall progression of IM was noted in 52.9% of subjects. Univariate analysis showed that persistent H pylori infection, age >45 years, male subjects, alcohol use, and drinking water from a well were significantly associated with IM progression. Duodenal ulcer and OAC treatment were associated with a reduced risk of histological progression. Progression of IM was more frequent in those with more extensive and more severe IM at baseline. With multiple logistic regression, duodenal ulcer (odds ratio (OR) 0.23 (95% confidence interval (CI) 0.09-0.58)) was found to be an independent protective factor against IM progression. Conversely, persistent H pylori infection (OR 2.13 (95% CI 1.41-3.24)), age >45 years (OR 1.92 (95% CI 1.18-3.11)), alcohol use (OR 1.67 (95% CI 1.07-2.62)), and drinking water from a well (OR 1.74 (95% CI 1.13-2.67)) were independent risk factors associated with IM progression.
Eradication of H pylori is protective against progression of premalignant gastric lesions.

1 Follower
 · 
72 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Determine the prevalence and distribution of gastric intestinal metaplasia (GIM) in a large cohort of patients subjected to esophagogastroscopy (EGD). Evaluate usefulness of grading the severity of gastritis, GIM and the impact of Helicobacter pylori (HP). Define the population at risk for gastric adenocarcinoma (GC) and assess the value of surveillance. In the course of 19 years, we performed 11,600 sequential EGDs in male veterans at Brooklyn, New York. Of all patients, 47 % had EGD only one time while 53 % had EGD repeated, 11 % of these had four or more EGDs. Patients with GIM were matched with equal number of controls with no GI symptoms. All gastric biopsies were processed in one laboratory, using the standardized protocol for histological staining and for grading the severity of epithelial changes. Of all patients subjected to EGD, 354 (3.05 %) were diagnosed with GIM. Compared to controls, GIM patients were older, 80 % were over 71. Regarding ethnicity, GIM was 5.4 % more frequent in 177 African Americans than in 159 Caucasians. Distribution of GIM did not differ with respect to age or ethnicity. As many as 6 %of GIM cases were diagnosed with GC. Grading of GIM severity had a predictive value, the average grade of severity in GC was 50 % higher than in non-cancer patients with GIM. Severity of gastritis was also a useful biomarker: patients with GC had more severe gastritis. Surprisingly, HP positivity had no predictive value: HP positive patients had similar distribution of GIM as the HP negative patients. Use of proton pump inhibitors in the past was unknown. Prevalence of GC in patients with GIM was more than 200 times higher than reported in normal population. Age more than 70 years and African Americans appeared to be at higher risk. Routine EGD and histological diagnosis, with simple grading of severity of epithelial changes provides a useful predictive information. Individuals with upper GI symptoms undergoing EGD with gastric biopsy benefited from routine clinical screening for GC. Patients with higher severity of GIM should enter surveillance (Tab. 1, Fig. 10, Ref. 45). gastric intestinal metaplasia, gastric adenocarcinoma, gastritis, histological severity, helicobacter pylori, african americans, endoscopy, surveillance.
    Bratislavske lekarske listy 01/2015; 116(1):3-8. DOI:10.4149/BLL_2015_001 · 0.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastric cancer is associated with high morbidity and mortal-ity worldwide. To reduce the socioeconomic burden related to gastric cancer, it is very important to identify and manage high risk group for gastric cancer. In this review, we describe the general risk factors for gastric cancer and define high risk group for gastric cancer. We discuss strategies for the effective management of patients for the prevention and early detection of gastric cancer. Atrophic gastritis (AG) and intestinal metaplasia (IM) are the most significant risk fac-tors for gastric cancer. Therefore, the accurate selection of individuals with AG and IM may be a key strategy for the prevention and/or early detection of gastric cancer. Although endoscopic evaluation using enhanced technologies such as narrow band imaging-magnification, the serum pepsinogen test, Helicobacter pylori serology, and trefoil factor 3 have been evaluated, a gold standard method to accurately select individuals with AG and IM has not emerged. In terms of managing patients at high risk of gastric cancer, it remains uncertain whether H. pylori eradication reverses and/or prevents the progression of AG and IM. Although endoscopic surveillance in high risk patients is expected to be beneficial, further prospective studies in large populations are needed to determine the optimal surveillance interval. (Gut Liver 2015;9:5-17).
    Gut and liver 01/2015; 9(1):5-17. DOI:10.5009/gnl14118 · 1.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gastric cancer is the second leading cause of cancer-related mortality and the fourth most common cancer globally. There are, however, distinct differences in incidence rates in different geographic regions. While the incidence rate of gastric cancer has been falling, that of gastric cardia cancers is reportedly on the rise in some regions. Helicobacter pylori (H. pylori) infection is a major risk factor of non-cardia gastric cancer, and data has emerged concerning the role of H. pylori eradication for primary prevention of gastric cancer. Dietary, lifestyle and metabolic factors have also been implicated. Although addressing these other factors may contribute to health, the actual impact in terms of cancer prevention is unclear. Once irreversible histological changes have occurred, endoscopic surveillance would be necessary. A molecular classification system offers hope for molecularly tailored, personalised therapies for gastric cancer, which may improve the prognosis for patients.
    Singapore medical journal 12/2014; 55(12):621-8. · 0.63 Impact Factor

Preview

Download
0 Downloads
Available from